Cargando…
HIV-associated wasting prevalence in the era of modern antiretroviral therapy
To understand the prevalence of HIV-associated wasting (HIVAW) in the United States. DESIGN: Medical and pharmacy claims study using IBM MarketScan Commercial, Medicare Supplemental and Medicaid Databases. METHODS: Study period: July 2012–September 2018 (first HIV diagnosis claim = HIV index date)....
Autores principales: | Siddiqui, Javeed, Samuel, Shanti K., Hayward, Brooke, Wirka, Kelly A., Deering, Kathleen L., Harshaw, Qing, Phillips, Amy, Harbour, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654247/ https://www.ncbi.nlm.nih.gov/pubmed/34628440 http://dx.doi.org/10.1097/QAD.0000000000003096 |
Ejemplares similares
-
Mortality and causes of death in people living with HIV in the era of combination antiretroviral therapy compared with the general population in Japan
por: Nishijima, Takeshi, et al.
Publicado: (2020) -
Risk factors for pneumococcal carriage in adults living with HIV on antiretroviral therapy in the infant pneumococcal vaccine era in Malawi
por: Thindwa, Deus, et al.
Publicado: (2022) -
Sexual behaviour in a rural high HIV prevalence South African community: time trends in the antiretroviral treatment era
por: McGrath, Nuala, et al.
Publicado: (2013) -
Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age
por: Ciaranello, Andrea L., et al.
Publicado: (2015) -
Potential impact on HIV incidence of higher HIV testing rates and earlier antiretroviral therapy initiation in MSM
por: Phillips, Andrew N., et al.
Publicado: (2015)